|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Lipid profile in women over 35 years old using triphasic combined oral |
| contraceptives. [Perfil lipídico de las mujeres de más de 35 años que |
| utilizan anticonceptivos orales combinados trifásicos.] |
| Aldrighi JM; Petta CA; Bahamondes L; Caetano ME; Martinez TR |
| Contraception. 2004 May;69(5):395-399. |
| Twenty-nine women aged 35 years old or more, using triphasic combined oral contraceptive (COC) were evaluated |
| during six cycles for the following parameters: total cholesterol, low-density lipoprotein cholesterol (LDL-C), high- |
| density lipoprotein cholesterol (HDL-C) and its subfraction HDL/2, triglycerides, apoproteins A and B, Castelli risk |
| index I and II (cholesterol/HDL-C and LDL-C/HDL-C) and apoprotein ratio (apoprotein B/apoprotein A). The same |
| laboratory measurements were done in a control group of 49 non-COC-user women. The results showed that there |
| were no differences on most of the studied parameters between user and nonuser women. There was a significant |
| reduction of HDL-C and HDL2-C, although within the normal range. In addition, it was observed a significant |
| increment of triglycerides and apoprotein B at 6 months of follow-up only in user group (p < 0.05), although within the |
| normal range. It is concluded that the use of levonorgestrel triphasic COC appeared to have no additional adverse |
| impact when used by women aged over 35 years. Further studies are needed to obtain conclusive data. |
| (PubHealth.info Document ID: CONT1T 579-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Lipid profile in women over 35 years old using triphasic |
| combined oral contraceptives. [Perfil lipídico de las mujeres de más de 35 años que utilizan anticonceptivos orales |
| combinados trifásicos.]", is(are) Aldrighi JM; Petta CA; Bahamondes L; Caetano ME; Martinez TR. The source of |
| this article is "Contraception. 2004 May;69(5):395-399.". This article was published in 2004 in English language(s). |
| (PubHealth.info® Document ID: CONT1T 579-06. All rights reserved with PubHealth.info) PIN: 579 |
| This article is peer-reviewed. |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |